靶点针对疾病信息17(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Glutamate receptor ionotropic NMDA 2B (NMDAR2B)
INDICATI
Approved Alpha-1-antitrypsin deficiency [ICD-11: 5C5A]
INDICATI
Approved Chronic pain [ICD-11: MG30]
INDICATI
Phase 2 Cerebral ischaemic stroke [ICD-11: 8B11]
INDICATI
Phase 2 Depression [ICD-11: 6A70-6A7Z]
INDICATI
Phase 2 Epilepsy/seizure [ICD-11: 8A61-8A6Z]
INDICATI
Phase 2 Neuropathy [ICD-11: 8C0Z]
INDICATI
Phase 2 Parkinsonism [ICD-11: 8A00]
INDICATI
Phase 1 Cardiac arrest [ICD-11: MC82]
INDICATI
Phase 1 Dissociative neurological symptom disorder [ICD-11: 6B60]
INDICATI
Discontinued in Phase 2 General pain disorder [ICD-11: 8E43]
INDICATI
Terminated Cerebral ischaemia [ICD-11: 8B1Z]
INDICATI
Terminated Neurodegenerative disorder [ICD-11: 8A20-8A23]
INDICATI
Investigative Intracranial injury [ICD-11: NA07]